183 related articles for article (PubMed ID: 12727930)
61. Immune Landscape of Pituitary Tumors Reveals Association Between Macrophages and Gonadotroph Tumor Invasion.
Principe M; Chanal M; Ilie MD; Ziverec A; Vasiljevic A; Jouanneau E; Hennino A; Raverot G; Bertolino P
J Clin Endocrinol Metab; 2020 Nov; 105(11):. PubMed ID: 32785693
[TBL] [Abstract][Full Text] [Related]
62. Pharmacological management of secreting pituitary tumors.
Gordon BM
J Neurosci Nurs; 2007 Feb; 39(1):52-7. PubMed ID: 17396539
[TBL] [Abstract][Full Text] [Related]
63. Combined effects of resveratrol and radiation in GH3 and TtT/GF pituitary adenoma cells.
Voellger B; Waldt N; Rupa R; Kirches E; Melhem O; Ochel HJ; Mawrin C; Firsching R
J Neurooncol; 2018 Sep; 139(3):573-582. PubMed ID: 29872948
[TBL] [Abstract][Full Text] [Related]
64. Solution- and solid-phase synthesis of peptide-substituted thiazolidinediones as potential PPAR ligands.
Mohler DL; Shen G; Dotse AK
Bioorg Med Chem Lett; 2000 Oct; 10(20):2239-42. PubMed ID: 11055328
[TBL] [Abstract][Full Text] [Related]
65. Pituitary tumorigenesis and hPit-1 cells.
Pardo FS; Leon S; Carroll R; Black P; Atkins L
Cancer Genet Cytogenet; 2001 Jul; 128(2):148-53. PubMed ID: 11463454
[TBL] [Abstract][Full Text] [Related]
66. Folate receptor-mediated drug targeting: a possible strategy for nonfunctioning pituitary adenomas?
Lee M; Pellegata NS
Endocrinology; 2013 Apr; 154(4):1387-9. PubMed ID: 23525581
[No Abstract] [Full Text] [Related]
67. A 48-YEar-Old Male with a Pituitary Tumor.
Forest F; Casteillo F; Manet R; Boutet C; Habougit C; Yvorel V; Duthel R; Péoc'h M
Brain Pathol; 2016 Jan; 26(1):130-1. PubMed ID: 26574710
[No Abstract] [Full Text] [Related]
68. Secondary diabetes mellitus in acromegaly.
Moustaki M; Paschou SA; Xekouki P; Kotsa K; Peppa M; Psaltopoulou T; Kalantaridou S; Vryonidou A
Endocrine; 2023 Jul; 81(1):1-15. PubMed ID: 36882643
[TBL] [Abstract][Full Text] [Related]
69. Diagnostic and therapeutic biomarkers in colorectal cancer: a review.
de Assis JV; Coutinho LA; Oyeyemi IT; Oyeyemi OT; Grenfell RFEQ
Am J Cancer Res; 2022; 12(2):661-680. PubMed ID: 35261794
[TBL] [Abstract][Full Text] [Related]
70. Prenatal exposure to the phthalate DEHP impacts reproduction-related gene expression in the pituitary.
Ge X; Weis K; Flaws J; Raetzman L
Reprod Toxicol; 2022 Mar; 108():18-27. PubMed ID: 34954075
[TBL] [Abstract][Full Text] [Related]
71. Treatment of acromegaly by rosiglitazone via upregulating 15-PGDH in both pituitary adenoma and liver.
Zhang Y; Wang M; Ji C; Chen Z; Yang H; Wang L; Yu Y; Qiao N; Ma Z; Ye Z; Shao X; Liu W; Wang Y; Gong W; Melnikov V; Hu L; Lee EJ; Ye H; Wang Y; Li Y; He M; Zhao Y; Zhang Z
iScience; 2021 Sep; 24(9):102983. PubMed ID: 34485865
[TBL] [Abstract][Full Text] [Related]
72. Guggulsterone ameliorates ethidium bromide-induced experimental model of multiple sclerosis via restoration of behavioral, molecular, neurochemical and morphological alterations in rat brain.
Kumar N; Sharma N; Khera R; Gupta R; Mehan S
Metab Brain Dis; 2021 Jun; 36(5):911-925. PubMed ID: 33635478
[TBL] [Abstract][Full Text] [Related]
73. Integrated multi-omics profiling of nonfunctioning pituitary adenomas.
Wei Z; Zhou C; Li M; Huang R; Deng H; Shen S; Wang R
Pituitary; 2021 Jun; 24(3):312-325. PubMed ID: 33205234
[TBL] [Abstract][Full Text] [Related]
74. Rosiglitazone affects the progression of surgically‑induced endometriosis in a rat model.
Zhang S; Zhuang L; Liu Q; Yu X; Min Q; Chen M; Chen Q
Mol Med Rep; 2021 Jan; 23(1):. PubMed ID: 33179107
[TBL] [Abstract][Full Text] [Related]
75. CB13, a novel PPARγ ligand, overcomes radio-resistance via ROS generation and ER stress in human non-small cell lung cancer.
Kim TW; Hong DW; Hong SH
Cell Death Dis; 2020 Oct; 11(10):848. PubMed ID: 33051435
[TBL] [Abstract][Full Text] [Related]
76. Nuclear Receptors as Regulators of Pituitary Corticotroph Pro-Opiomelanocortin Transcription.
Zhang D; Heaney AP
Cells; 2020 Apr; 9(4):. PubMed ID: 32272677
[TBL] [Abstract][Full Text] [Related]
77. PPAR-Mediated Toxicology and Applied Pharmacology.
Xi Y; Zhang Y; Zhu S; Luo Y; Xu P; Huang Z
Cells; 2020 Feb; 9(2):. PubMed ID: 32028670
[TBL] [Abstract][Full Text] [Related]
78. The Pathophysiology and Treatment of Hypertension in Patients With Cushing's Syndrome.
Barbot M; Ceccato F; Scaroni C
Front Endocrinol (Lausanne); 2019; 10():321. PubMed ID: 31164868
[TBL] [Abstract][Full Text] [Related]
79. Peroxisome Proliferator-Activated Receptor gamma negatively regulates liver regeneration after partial hepatectomy via the HGF/c-Met/ERK1/2 pathways.
Cheng Z; Liu L; Zhang XJ; Lu M; Wang Y; Assfalg V; Laschinger M; von Figura G; Sunami Y; Michalski CW; Kleeff J; Friess H; Hartmann D; Hüser N
Sci Rep; 2018 Aug; 8(1):11894. PubMed ID: 30089804
[TBL] [Abstract][Full Text] [Related]
80. Pituitary-Directed Therapies for Cushing's Disease.
Langlois F; Chu J; Fleseriu M
Front Endocrinol (Lausanne); 2018; 9():164. PubMed ID: 29765354
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
